Particular human leukocyte antigen alleles are associated with biochemical traits in the Japanese population

Human Immunology

Volumn 72, Issue 7, 2011, Pages 566-570

  Mitsunaga, Shigeki ^a   Homma, Yasuhiko ^a   Narita, Akira ^a   Kashiwase, Koichi ^b   Okudaira, Yuko ^a   Shiina, Yutaka ^a   Inoue, Ituro ^a   Inoko, Hidetoshi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Japanese Red Cross Tokyo Blood Center   (Japan)

Author keywords

Association; Biochemical trait; HLA

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HLA ANTIGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALLELE; ARTICLE; BIOLOGICAL TRAIT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; FISHER EXACT TEST; GENE LOCUS; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HLA TYPING; HUMAN; JAPANESE; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL; RANK SUM TEST;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MIDDLE AGED; QUANTITATIVE TRAIT LOCI;

EID: 79958291364     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.03.011     Document Type: Article

References (35)

1. Zanelli E., Breedveld F.C., de Vries R.R. HLA association with autoimmune disease: a failure to protect?. Rheumatol Oxf 2000, 39:1060-1066.
2. Talken B.L., Schäfermeyer K.R., Bailey C.W., Lee D.R., Hoffman R.W. T cell epitope mapping of the Smith antigen reveals that highly conserved Smith antigen motifs are the dominant target of T cell immunity in systemic lupus erythematosus. J Immunol 2001, 167:562-568.
3. Shiina T., Hosomichi K., Inoko H., Kulski J.K. The HLA genomic loci map: expression, interaction, diversity and disease. J Hum Genet 2009, 54:15-39.
4. Joseph A., Brasington R., Kahl L., Ranganathan P., Cheng T.P., Atkinson J. Immunologic rheumatic disorders. J Allergy Clin Immunol 2010, 125:S204-S215.
5. Choy E.H., Panayi G.S. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 2001, 344:907-916.
6. Breedveld F.C., van der Lubbe P.A. Monoclonal antibody therapy of inflammatory rheumatic diseases. Br Med Bull 1995, 51:493-502.
7. Maini R.N., Elliott M.J., Brennan F.M., Williams R.O., Chu C.Q., Paleolog E., et al. Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 1995, 144:195-223.
8. Wellen K.E., Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 2005, 115:1111-1119.
9. Semenkovich C.F. Insulin resistance and atherosclerosis. J Clin Invest 2006, 116:1813-1822.
10. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
11. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993, 259:87-91.
12. Uysal K.T., Wiesbrock S.M., Marino M.W., Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997, 389:610-614.
13. Vozarova B., Weyer C., Hanson K., Tataranni P.A., Bogardus C., Pratley R.E. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001, 9:414-417.
14. Bastard J.P., Maachi M., Van Nhieu J.T., Jardel C., Bruckert E., Grimaldi A., et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002, 87:2084-2089.
15. Navab M., Anantharamaiah G.M., Reddy S.T., Van Lenten B.J., Fogelman A.M. HDL as a biomarker, potential therapeutic target, and therapy. Diabetes 2009, 58:2711-2717.
16. Haas M.J., Mooradian A.D. Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease. Diabetes/Metab Res Rev 2010, 26:90-99.
17. Park Y.B., Choi H.K., Kim M.Y., Lee W.K., Song J., Kim D.K., et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002, 113:188-193.
18. Svenungsson E., Fei G.Z., Jensen-Urstad K., de Faire U., Hamsten A., Frostegard J. TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease. Lupus 2003, 12:454-461.
19. Escárcega R.O., García-Carrasco M., Fuentes-Alexandro S., Jara L.J., Rojas-Rodriguez J., Escobar-Linares L.E., et al. Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease. Autoimmun Rev 2006, 6:48-53.
20. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39:175-191.
21. Stephens M., Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003, 73:1162-1169.
22. Shibata T., Ogushi Y., Ogawa T., Kanno T. Estimation of sex-age specific clinical reference ranges by nonlinear optimization method. Stud Health Technol Inform 2005, 116:229-234.
23. Nakajima F., Nakamura J., Yokota T. Analysis of HLA haplotypes in Japanese, using high resolution allele typing. MHC 2001, 8:1-32. (in Japanese).
24. Sabatti C., Service S.K., Hartikainen A.L., Pouta A., Ripatti S., Brodsky J., et al. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat Genet 2009, 41:35-46.
25. Aulchenko Y.S., Ripatti S., Lindqvist I., Boomsma D., Heid I.M., Pramstaller P.P., et al. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet 2009, 41:47-55.
26. Kathiresan S., Willer C.J., Peloso G.M., Demissie S., Musunuru K., Schadt E.E., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009, 41:56-65.
27. Teslovich T.M., Musunuru K., Smith A.V., Edmondson A.C., Stylianou I.M., Koseki M., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 466:707-713.
28. Kamatani Y., Matsuda K., Okada Y., Kubo M., Hosono N., Daigo Y., et al. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nat Genet 2010, 42:210-215.
29. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008, 40:161-169.
30. Forsblom C.M., Sane T., Groop P.H., Tötterman K.J., Kallio M., Saloranta C., et al. Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia 1998, 41:1253-1262.
31. Wang F., Liu H., Blanton W.P., Belkina A., Lebrasseur N.K., Denis G.V., et al. Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem J 2009, 425:71-83.
32. Bonnefond A., Froguel P., Vaxillaire M. The emerging genetics of type 2 diabetes. Trends Mol Med 2010, 16:407-416.
33. Solini A., Muscelli E., Stignani M., Melchiorri L., Santini E., Rossi C., et al. Soluble human leukocyte antigen-g expression and glucose tolerance in subjects with different degrees of adiposity. J Clin Endocrinol Metab 2010, 95:3342-3346.
34. Chen X.Y., Yan W.H., Lin A., Xu H.H., Zhang J.G., Wang X.X. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008, 72:335-341.
35. Kolte A.M., Steffensen R., Nielsen H.S., Hviid T.V., Christiansen O.B. Study of the structure and impact of human leukocyte antigen (HLA)-G-A, HLA-G-B, and HLA-G-DRB1 haplotypes in families with recurrent miscarriage. Hum Immunol 2010, 71:482-488.